These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

141 related items for PubMed ID: 3117888

  • 1. Immune regulation of the L5178Y murine tumor-dormant state. II. Interferon-gamma requires tumor necrosis factor to restrain tumor cell growth in peritoneal cell cultures from tumor-dormant mice.
    Suzuki Y, Liu CM, Chen LP, Ben-Nathan D, Wheelock EF.
    J Immunol; 1987 Nov 01; 139(9):3146-52. PubMed ID: 3117888
    [Abstract] [Full Text] [Related]

  • 2. Maintenance and cure of the L5178Y murine tumor-dormant state by interleukin 2: dependence of interleukin 2 on induced interferon-gamma and on tumor necrosis factor for its antitumor effects.
    Chen LP, Suzuki Y, Liu CM, Wheelock EF.
    Cancer Res; 1990 Mar 01; 50(5):1368-74. PubMed ID: 2105837
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Phenotypic shifts in the L5178Y lymphoma population during progression of the tumor-dormant state in DBA/2 mice.
    Trainer DL, Wheelock EF.
    Cancer Res; 1984 Mar 01; 44(3):1063-71. PubMed ID: 6607108
    [Abstract] [Full Text] [Related]

  • 7. Enhanced suppressor macrophage activity associated with termination of the L5178Y cell tumor-dormant state in DBA/2 mice.
    Robinson MK, Truitt GA, Okayasu T, Wheelock EF.
    Cancer Res; 1983 Dec 01; 43(12 Pt 1):5831-6. PubMed ID: 6227383
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Tumoricidal activation of murine resident peritoneal macrophages by interleukin 2 and tumor necrosis factor alpha.
    Verstovsek S, Maccubbin D, Ehrke MJ, Mihich E.
    Cancer Res; 1992 Jul 15; 52(14):3880-5. PubMed ID: 1617664
    [Abstract] [Full Text] [Related]

  • 11. Interferon-gamma exerts its negative regulatory effect primarily on the earliest stages of murine erythroid progenitor cell development.
    Wang CQ, Udupa KB, Lipschitz DA.
    J Cell Physiol; 1995 Jan 15; 162(1):134-8. PubMed ID: 7814445
    [Abstract] [Full Text] [Related]

  • 12. Elimination of L5178Y cells from tumor-dormant DBA/2 mice by specific active immunotherapy.
    Marsili MA, Robinson MK, Truitt GA, Wheelock EF.
    Cancer Res; 1983 Jan 15; 43(1):15-21. PubMed ID: 6600159
    [Abstract] [Full Text] [Related]

  • 13. Resistance of Ha-ras oncogene-induced progressor tumor variants to tumor necrosis factor and interferon-gamma.
    Fernandez A, Chen PW, Aggarwal BB, Ananthaswamy HN.
    Lymphokine Cytokine Res; 1992 Apr 15; 11(2):79-85. PubMed ID: 1581420
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Potentiation of lymphokine-induced macrophage activation by tumor necrosis factor-alpha.
    Heidenreich S, Weyers M, Gong JH, Sprenger H, Nain M, Gemsa D.
    J Immunol; 1988 Mar 01; 140(5):1511-8. PubMed ID: 3126228
    [Abstract] [Full Text] [Related]

  • 16. Modulation of immune effector cell cytolytic activity and tumour growth inhibition in vivo by Ukrain (NSC 631570).
    Liepins A, Nowicky JW.
    Drugs Exp Clin Res; 1996 Mar 01; 22(3-5):103-13. PubMed ID: 8899312
    [Abstract] [Full Text] [Related]

  • 17. Comparative effects of various classes of mouse interferons on macrophage activation for tumor cell killing.
    Pace JL, Russell SW, LeBlanc PA, Murasko DM.
    J Immunol; 1985 Feb 01; 134(2):977-81. PubMed ID: 2578167
    [Abstract] [Full Text] [Related]

  • 18. Endogenous accumulation of IFN-gamma in IFN-gamma-R(-/-) mice increases resistance to B16F10-Nex2 murine melanoma: a model for direct IFN-gamma anti-tumor cytotoxicity in vitro and in vivo.
    Rodrigues EG, Garofalo AS, Travassos LR.
    Cytokines Cell Mol Ther; 2002 Feb 01; 7(3):107-16. PubMed ID: 12850810
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Adoptive immunotherapy of syngeneic murine leukemia is enhanced by the combination of recombinant IFN-gamma and a tumor-specific cytotoxic T cell clone.
    de Graaf PW, Horak E, Bookman MA.
    J Immunol; 1988 Apr 15; 140(8):2853-7. PubMed ID: 3128613
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.